The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 39 | — | 20.1x | Near average | |
Growth | 24 | -8.7% | 5.6% | Below average | |
Quality | 40 | -5.7% | 7.6% | Near average | |
Safety | 25 | 21.5x | 0.4x | Below average | |
Capital Return | 35 | — | 2.19% | Near average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Calumet, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Calumet, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
Calumet stock shows a negative gap between the current market price (37.37) and the average analyst price target (31), indicating that the stock is currently trading at a premium exceeding fair value estimates. Although the average target has remained stable at $31 over the past thirty days, the general outlook leans toward caution with a variance in targets between $26 and $36, both of which are lower than the current price.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.